Clinical trial
To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given…
NCT00090714 · Corautus Genetics, Industry · Unknown status
Key facts
| NCT number | NCT00090714 |
|---|---|
| Title | To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter |
| Lead sponsor | Corautus Genetics, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Angina Pectoris |
| Intervention type | Genetic |
| Interventions | pVGI.1(VEGF2) |
| Enrollment | 404 |
| Start date | Aug 1, 2004 |
| First posted | Sep 6, 2004 |
| Last update posted | Apr 20, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: